Tenaya Therapeutics to Participate in Upcoming Investor Conferences
January 31 2022 - 8:00AM
Business Wire
Tenaya Therapeutics, Inc. (NASDAQ:TNYA), a biotechnology company
with a mission to discover, develop and deliver curative therapies
that address the underlying causes of heart disease, today
announced participation at several upcoming investor
conferences.
Details of each presentation are as follows:
Cowen 2nd Annual Genetic Medicines Summit Panel: Gene
Therapies - Clinical Topics Date: Thursday, February 3, 2022 Time:
12:00 p.m. ET
SVB Leerink Global Healthcare Conference Company
Presentation Date: Friday, February 18, 2022 Time: 3:40 p.m. ET
Cowen 42nd Annual Health Care Conference Panel: Gene
Therapy Date: Wednesday March 9, 2022 Time: 12:50 p.m. ET
About Tenaya Therapeutics
Tenaya Therapeutics is a biotechnology company committed to a
bold mission: to discover, develop and deliver curative therapies
that address the underlying drivers of heart disease. Founded by
leading cardiovascular scientists from Gladstone Institutes and the
University of Texas Southwestern Medical Center, Tenaya is
developing therapies for rare genetic disorders as well as for more
prevalent heart conditions through three distinct but interrelated
product platforms: Gene Therapy, Cellular Regeneration and
Precision Medicine. For more information, visit
www.tenayatherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220131005192/en/
Investors Leone Patterson Tenaya Therapeutics
IR@tenayathera.com
Media Wendy Ryan Ten Bridge Communications
Wendy@tenbridgecommunications.com
Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tenaya Therapeutics (NASDAQ:TNYA)
Historical Stock Chart
From Apr 2023 to Apr 2024